C-Reactive Protein Testing Market: By Assay Type, By Detection Range, By Disease Area, By End-use and Region  

C-Reactive Protein Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others), By End-use (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others) and Region  

C-Reactive Protein Testing Market size was valued at US$ 2,892.2 million in 2023 and is poised to grow at a significant CAGR of 2.7% from 2024-2030. C-reactive protein testing (CRP), an acute-phase protein produced by the liver, increases in concentration in the blood due to an inflammatory disorder. The CRP test detects the amount of CRP in blood cells. This test identifies various types of infections such as Cardiovascular diseases, Arthritis, Cancer, etc. The increase in the geriatric population globally and the growing prevalence of infectious and chronic diseases such as cancer, diabetes, cardiovascular, and arthritis are some of the primary factors that can propel the growth of the CPR market.

Moreover, lower immunity and shifting toward an inactive lifestyle raise the demand for healthcare services which helps in the growth of the CPR market. Additionally, various initiatives are taken by the government, prominent market players, and non-profit organizations to increase awareness of CPR testing which can further boost the market growth.

Furthermore, the presence of numerous rapid kits and point-of-care devices has promoted the growth of the CPR market. However, a wide variety of alternative disease testing approaches which is more accurate such as an echocardiogram (ultrasound), and electrocardiogram (ECG) for cardiac disease screening can hinder the market CPR growth. CPR testing has the ability to differentiate between pathological and physiological CPR levels which can treat inflammatory illnesses has created lucrative opportunities for new players to enter the market. Nevertheless, increasing healthcare demands and improved healthcare infrastructures have created an attractive opportunity to expand the market size. The key trend in the CPR market is the initiatives taken by the government to encourage the usage of point-of-care testing in healthcare centers which can further support to boost the CPR market.

Key Developments

  • In January 2021, DM Vasudevan Agappe Diagnostic Limited, India verified the usage of the latex-supplemented immunoturbidimetric assay for a highly sensitive and extensive variety of C-reactive protein detection in human serum.
  • In July 2022, Bloom Diagnostics launched an inflammation test kit to detect and measure the presence of CPR.

C Reactive Protein Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

2.7%

Largest Market

Asia-Pacific

Fastest Growing Market

North America

C-Reactive Protein Testing Market Dynamics

The global C-reactive protein testing market is primarily driven by an increase in the prevalence of inflammatory diseases. As the number of the aging population is rising globally, and rise in chronic and cardiovascular diseases is observed. Due to this, CPR testing is implemented as a prime diagnostic tool which is expected to increase the market share in the coming next few years. Additionally, rising public and private funding for research and development of CPR are further expected to expand the CRP market globally.

C Reactive Protein Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2,892.2 million

Market CAGR

2.7%

By Assay Type

  • Immunoturbidimetric Assay
  • ELISA (Clinical, Non-Clinical)
  • Chemiluminescence Immunoassay
  • Others

By Detection Range

  • hs-CRP
  • Conventional CRP
  • cCRP

By Disease Type

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

By End User

  • Clinics (By Entity, By Settings)
  • Hospitals (Urban Settings, Rural Settings)
  • Laboratories (Urban Settings, Rural Settings)
  • Assisted Living Healthcare Facilities (Urban Settings, Rural Settings)
  • Home
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Features of the Report

  • The c-reactive protein testing market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market.

Download Free Sample Report

Frequently Asked Questions

The global c reactive protein testing market size was valued at US$ 2,892.2 million in 2023 and is projected to grow at a CAGR of 2.7% from 2024-2030.

Key players’ profiles in the c-reactive protein testing market report are Thermo Fisher Scientific, inc., F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers AG, Abbott, Merck KGaAA, Zoetis, Ortho Clinical Diagnostics, Getein Biotech.

A rise in the geriatric population, an increase in chronic diseases growing R&D activities in C-reactive protein testing, and government initiatives to promote point-to-care testing which uses CPR testing.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global C-Reactive Protein Testing Market Introduction
2.1. Global C-Reactive Protein Testing Market Taxonomy
2.2. Global C-Reactive Protein Testing Market Definitions
2.2.1. By Assay Type
2.2.2. By Detection Range
2.2.3. By Disease Area
2.2.4. By End-use
2.2.5. By Region
3. Global C-Reactive Protein Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global C-Reactive Protein Testing Market Dynamic Factors - Impact Analysis
3.6. Global C-Reactive Protein Testing Market Competition Landscape
4. Global C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global C-Reactive Protein Testing Market, By Assay Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Immunoturbidimetric Assay
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. ELISA
5.2.1. Clinical
5.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Non-clinical
5.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.3. Chemiluminescence Immunoassay
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global C-Reactive Protein Testing Market, By Detection Range, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. hs-CRP
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Conventional CRP
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. cCRP
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global C-Reactive Protein Testing Market, By Disease Area, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Cardiovascular Diseases
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Cancer
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Rheumatoid Arthritis
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Inflammatory Bowel Disease
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Endometriosis
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Lupus
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global C-Reactive Protein Testing Market, By End-use, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Clinics
8.1.1. By Entity
8.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.1.3. Market Opportunity Analysis
8.1.2. By Settings
8.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.2.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Urban Setting
8.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.1.3. Market Opportunity Analysis
8.2.2. Rural Setting
8.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.2.3. Market Opportunity Analysis
8.3. Laboratories
8.3.1. Urban Setting
8.3.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.1.3. Market Opportunity Analysis
8.3.2. Rural Setting
8.3.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.2.3. Market Opportunity Analysis
8.4. Assisted Living Healthcare Facilities
8.4.1. Urban Setting
8.4.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.1.3. Market Opportunity Analysis
8.4.2. Rural Setting
8.4.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.2.3. Market Opportunity Analysis
8.5. Home
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Others
8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
9. Global C-Reactive Protein Testing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Region, 2024 - 2030
10. North America C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Immunoturbidimetric Assay
10.1.2. ELISA
10.1.2.1. Clinical
10.1.2.2. Non-clinical
10.1.3. Chemiluminescence Immunoassay
10.1.4. Others
10.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. hs-CRP
10.2.2. Conventional CRP
10.2.3. cCRP
10.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cardiovascular Diseases
10.3.2. Cancer
10.3.3. Rheumatoid Arthritis
10.3.4. Inflammatory Bowel Disease
10.3.5. Endometriosis
10.3.6. Lupus
10.3.7. Others
10.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Clinics
10.4.1.1. By Entity
10.4.1.2. By Settings
10.4.2. Hospitals
10.4.2.1. Urban Setting
10.4.2.2. Rural Setting
10.4.3. Laboratories
10.4.3.1. Urban Setting
10.4.3.2. Rural Setting
10.4.4. Assisted Living Healthcare Facilities
10.4.4.1. Urban Setting
10.4.4.2. Rural Setting
10.4.5. Home
10.4.6. Others
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030
10.7. North America C-Reactive Protein Testing Market Dynamics Trends
11. Europe C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Immunoturbidimetric Assay
11.1.2. ELISA
11.1.2.1. Clinical
11.1.2.2. Non-clinical
11.1.3. Chemiluminescence Immunoassay
11.1.4. Others
11.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. hs-CRP
11.2.2. Conventional CRP
11.2.3. cCRP
11.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cardiovascular Diseases
11.3.2. Cancer
11.3.3. Rheumatoid Arthritis
11.3.4. Inflammatory Bowel Disease
11.3.5. Endometriosis
11.3.6. Lupus
11.3.7. Others
11.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinics
11.4.1.1. By Entity
11.4.1.2. By Settings
11.4.2. Hospitals
11.4.2.1. Urban Setting
11.4.2.2. Rural Setting
11.4.3. Laboratories
11.4.3.1. Urban Setting
11.4.3.2. Rural Setting
11.4.4. Assisted Living Healthcare Facilities
11.4.4.1. Urban Setting
11.4.4.2. Rural Setting
11.4.5. Home
11.4.6. Others
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030
11.7. Europe C-Reactive Protein Testing Market Dynamics Trends
12. Asia-Pacific C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Immunoturbidimetric Assay
12.1.2. ELISA
12.1.2.1. Clinical
12.1.2.2. Non-clinical
12.1.3. Chemiluminescence Immunoassay
12.1.4. Others
12.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. hs-CRP
12.2.2. Conventional CRP
12.2.3. cCRP
12.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cardiovascular Diseases
12.3.2. Cancer
12.3.3. Rheumatoid Arthritis
12.3.4. Inflammatory Bowel Disease
12.3.5. Endometriosis
12.3.6. Lupus
12.3.7. Others
12.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinics
12.4.1.1. By Entity
12.4.1.2. By Settings
12.4.2. Hospitals
12.4.2.1. Urban Setting
12.4.2.2. Rural Setting
12.4.3. Laboratories
12.4.3.1. Urban Setting
12.4.3.2. Rural Setting
12.4.4. Assisted Living Healthcare Facilities
12.4.4.1. Urban Setting
12.4.4.2. Rural Setting
12.4.5. Home
12.4.6. Others
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030
12.7. Asia-Pacific C-Reactive Protein Testing Market Dynamics Trends
13. Latin America C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Immunoturbidimetric Assay
13.1.2. ELISA
13.1.2.1. Clinical
13.1.2.2. Non-clinical
13.1.3. Chemiluminescence Immunoassay
13.1.4. Others
13.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. hs-CRP
13.2.2. Conventional CRP
13.2.3. cCRP
13.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cardiovascular Diseases
13.3.2. Cancer
13.3.3. Rheumatoid Arthritis
13.3.4. Inflammatory Bowel Disease
13.3.5. Endometriosis
13.3.6. Lupus
13.3.7. Others
13.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinics
13.4.1.1. By Entity
13.4.1.2. By Settings
13.4.2. Hospitals
13.4.2.1. Urban Setting
13.4.2.2. Rural Setting
13.4.3. Laboratories
13.4.3.1. Urban Setting
13.4.3.2. Rural Setting
13.4.4. Assisted Living Healthcare Facilities
13.4.4.1. Urban Setting
13.4.4.2. Rural Setting
13.4.5. Home
13.4.6. Others
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030
13.7. Latin America C-Reactive Protein Testing Market Dynamics Trends
14. Middle East and Africa C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Immunoturbidimetric Assay
14.1.2. ELISA
14.1.2.1. Clinical
14.1.2.2. Non-clinical
14.1.3. Chemiluminescence Immunoassay
14.1.4. Others
14.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. hs-CRP
14.2.2. Conventional CRP
14.2.3. cCRP
14.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cardiovascular Diseases
14.3.2. Cancer
14.3.3. Rheumatoid Arthritis
14.3.4. Inflammatory Bowel Disease
14.3.5. Endometriosis
14.3.6. Lupus
14.3.7. Others
14.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinics
14.4.1.1. By Entity
14.4.1.2. By Settings
14.4.2. Hospitals
14.4.2.1. Urban Setting
14.4.2.2. Rural Setting
14.4.3. Laboratories
14.4.3.1. Urban Setting
14.4.3.2. Rural Setting
14.4.4. Assisted Living Healthcare Facilities
14.4.4.1. Urban Setting
14.4.4.2. Rural Setting
14.4.5. Home
14.4.6. Others
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd-use  Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030
14.7. MEA C-Reactive Protein Testing Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific, inc.
15.2.2. F. Hoffmann-La Roche Ltd.
15.2.3. Danaher
15.2.4. Quest Diagnostics
15.2.5. Siemens Healthineers AG
15.2.6. Abbott
15.2.7. Merck KGaAA
15.2.8. Zoetis
15.2.9. Ortho Clinical Diagnostics
15.2.10. Getein Biotech, Inc.
15.2.11. HORIBA, Ltd
15.2.12. Randox Laboratories Ltd.
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Thermo Fisher Scientific, inc.
  • Hoffmann-La Roche Ltd.
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech, Inc.
  • HORIBA, Ltd
  • Randox Laboratories Ltd.

Related Industry Reports